Step 1 topics → Reproductive → Cervical Cancer (SCC and Adenocarcinoma)

Cervical Cancer (SCC and Adenocarcinoma)

USMLE Step 1 trap: Incorrectly believes cervical adenocarcinoma is HPV-independent. Cervical adenocarcinoma is also HPV-associated (especially HPV 18), though SCC remains more common overall.

Cervical cancer is tested on USMLE Step 1 primarily through two lenses: histologic subtype recognition and clinical presentation. The exam wants you to distinguish squamous cell carcinoma (SCC) from adenocarcinoma in terms of frequency, location, and HPV association — and to recognize the red-flag presentations that should never be dismissed. SCC remains the most common type, arising from the transformation zone, but adenocarcinoma (arising from endocervical glandular cells) is increasing in incidence and is also HPV-driven. That distinction matters.

The trickiest part of this topic is that students often treat adenocarcinoma as an outlier that doesn't fit the HPV story — it does. HPV 18 has a particular affinity for glandular epithelium, making it the dominant driver of cervical adenocarcinoma. USMLE Step 1 passages may present a patient with an adenocarcinoma and expect you to correctly identify HPV (especially type 18) as the causative agent rather than defaulting to HPV 16 and SCC.

On the clinical side, the exam tests whether you correctly flag postcoital bleeding as a red-flag symptom requiring workup, not reassurance. And for advanced disease, you need to know the mechanism of death: lateral spread into the parametrium obstructs the ureters → hydronephrosis → renal failure. This is the most common cause of death in cervical cancer and shows up in USMLE Step 1 questions about late complications. Don't let it catch you off guard.

From real student decks
81%have cards covering this topic
65%have mature cards
1.0median lapses in 14 days

Common misconceptions

Common mistake
Wrong: Adenocarcinoma of the cervix is not HPV-associated, unlike SCC.
Right: Cervical adenocarcinoma is also HPV-associated (especially HPV 18), though SCC remains more common overall.
Students often assume that because adenocarcinoma arises from glandular cells rather than squamous epithelium, it follows a different pathogenesis. That's wrong. Cervical adenocarcinoma is absolutely HPV-associated — HPV 18 in particular has a strong tropism for endocervical glandular cells. When a Step 1 question describes cervical adenocarcinoma and asks about etiology, HPV (especially type 18) is still your answer.
Common mistake
Wrong: Postcoital bleeding in a young woman is most likely due to a hormonal cause or cervical ectropion and does not require urgent evaluation.
Right: Postcoital bleeding is a classic early presentation of cervical cancer and warrants colposcopy and biopsy, not reassurance alone.
Postcoital bleeding gets mentally filed under 'benign' by many students — cervical ectropion, hormonal changes, or partner trauma. But in the context of Step 1, postcoital bleeding in a sexually active woman is a red flag for cervical cancer until proven otherwise. The correct next step is colposcopy and biopsy, not reassurance. Early cervical cancer is often asymptomatic or presents only with this subtle bleeding, which is exactly why the exam uses it as a discriminating detail.
Common mistake
Gap: Missing that ureteral obstruction and renal failure are the leading cause of death in advanced cervical cancer
Advanced cervical cancer can cause lateral spread to obstruct the ureters, leading to hydronephrosis and renal failure — the most common cause of death in cervical cancer.
Many students know cervical cancer is dangerous but can't articulate the mechanism of death. Advanced cervical cancer spreads laterally into the parametrium — the connective tissue beside the uterus — and as it expands, it compresses the ureters where they pass through this space. This causes bilateral ureteral obstruction, hydronephrosis, and eventually renal failure. This is the #1 cause of death in cervical cancer, and knowing the anatomical rationale (ureters run through the parametrium) locks it in for good.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the classic presentation of cervical cancer — especially postcoital (post-intercourse) bleeding — and understand that this symptom requires colposcopy and biopsy, not watchful waiting.
  2. Understand the late-stage complications of cervical cancer, particularly lateral tumor spread causing ureteral obstruction, hydronephrosis, and ultimately renal failure as the leading cause of death.
  3. Distinguish SCC from adenocarcinoma of the cervix: SCC is more common and arises from the transformation zone; adenocarcinoma arises from endocervical glands — but both are HPV-associated.
  4. Know the HPV type association for each subtype: HPV 16 is most strongly linked to SCC, while HPV 18 is more associated with adenocarcinoma — both are high-risk oncogenic types.

Can you avoid these mistakes?

A 32-year-old woman presents with spotting after intercourse on three occasions over the past month. She is otherwise asymptomatic and her last Pap smear 3 years ago was normal. What is the most appropriate next step, and what diagnosis must be ruled out?
A biopsy of an endocervical lesion reveals malignant glandular cells forming irregular tubular structures. Which HPV subtype is most commonly associated with this histologic pattern, and how does this differ from the more common cervical cancer subtype?
A 55-year-old woman with known cervical cancer presents with bilateral flank pain, decreased urine output, and a creatinine of 6.2 mg/dL. What is the mechanism linking her cervical cancer to her current renal findings, and what is the significance of this complication?
A 38-year-old woman is diagnosed with cervical adenocarcinoma arising from endocervical glands. A student asserts this tumor is not HPV-related because it's glandular, not squamous, and therefore HPV vaccination would not have prevented it. Evaluate this reasoning — what HPV type is actually associated with cervical adenocarcinoma, and does the vaccine cover it?

Related topics

HPV and Cervical Dysplasia (CIN) Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →